CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
Malignant central nervous system tumors are the leading cause of cancer death in children. Progress in high-throughput molecular techniques has increased the molecular understanding of these tumors, but the outcomes are still poor. Even when efficacious, surgery, radiation, and chemotherapy cause ne...
Guardado en:
Autores principales: | Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray, Stéphane Birklé |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ae313db6a6094e169834075363a59a1f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
por: Viktoria Melcher, et al.
Publicado: (2021) -
An atypical teratoid/rhabdoid tumor (AT/RT) with molecular features of pleomorphic xanthoastrocytoma (PXA) in a 62-year-old patient
por: Matthias Dottermusch, et al.
Publicado: (2021) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
por: Nguyen Minh Duc
Publicado: (2021) -
Liquid Biopsy and Primary Brain Tumors
por: Robert H. Eibl, et al.
Publicado: (2021) -
CAR-T and other adoptive cell therapies for B cell malignancies
por: Peihua Lu, et al.
Publicado: (2021)